Discovery Talks is CFRI's new international seminar series. Featuring influential research leaders from around the globe, the series promotes knowledge exchange, fosters international collaborations and showcases the brightest minds in research.
Thursday, May 26, 2016
1:00 - 2:00 p.m. | Chan Centre for Family Health Education (CFRI Auditorium)
Entrance #18 of BC Children's Hospital, 938 West 28th Avenue, Vancouver, BC
Presented by CFRI's Childhood Diseases research theme
Dr. Peter C. Adamson, Professor of Pediatrics and Pharmacology
Perelman School of Medicine of the University of Pennsylvania
"Improving the Outcome for Children with Cancer: The Costs of Risk Aversion"
Please RSVP. Can't make it in person? Videoconferencing is available.
| ||About the speaker: Dr. Peter Adamson is Chair of the Children’s Oncology Group (COG), a National Cancer Institute (NCI) supported international consortium of more than 220 childhood centers that conducts clinical-translational research, including large-scale clinical trials, in children with cancer.He is Professor of Pediatrics and Pharmacology at the Perelman School of Medicine of the University of Pennsylvania and he holds the Alan R. Cohen Endowed Chair in Pediatrics at The Children’s Hospital of Philadelphia (CHOP). Dr. Adamson is Board Certified in Pediatric Hematology/Oncology and in Clinical Pharmacology. He currently serves on the National Cancer Advisory Board (NCAB) and is an internationally recognized leader in pediatric cancer drug development. He has also been has been appointed a member of the Blue Ribbon Panel of cancer leaders that will help direct the goals of Vice President Joe Biden’s National Cancer Moonshot Initiative. His laboratory research focuses on the clinical pharmacology of new drugs for childhood cancer. |